The study of tumor viruses paves the way for understanding the mechanisms of virus
pathogenesis, including those involved in establishing infection and dissemination in the …

Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) causes neoplastic transformation of
human T-cells in a small number of infected individuals several years from infection …

We report the identification and characterization of a new variant of HTLV‐I in an African
patient with adult T‐cell leukemia/lymphoma (ATL). Proviral sequences were detected by …

Human T-lymphotropic virus type 1 (HTLV-1) is the causative agent for adult T-cell
leukemia/lymphoma (ATL). 1–3 Only a small proportion of HTLV-1 carriers eventually …

In the early 1980s, the first human retrovirus, human T‐cell leukemia virus type I (HTLV‐I),
was isolated and its characterization opened up the new field of human viral oncology. Adult …

Human T-cell lymphotropic virus (HTLV) types 1 and 2 belong to the Oncorna group of
retroviridae, a large family of viruses, grouped initially by pathogenic features, but later …

In the 10 year period since its discovery, human T cell leukemia virus type II (HTLV-II) has
emerged as a significant human pathogen. Infection has been shown to be endemic in a …

The human T-cell leukemia virus type 1 (HTLV-1) is the only known human oncogenic
retrovirus. HTLV-1 can cause a type of cancer called adult T-cell leukemia/lymphoma (ATL) …

The main mechanisms of interaction between Human T‐lymphotropic virus type 1 (HTLV‐1)
and its hosts in the manifestation of the related disease including HTLV‐1 associated …

Objective (s): Human T Lymphocyte Virus Type one (HTLV-I) is a retrovirus that infects about
10-20 million people worldwide. Khorasan province in Iran is an endemic area. The majority …